Nasdaq:US$13.33 (+0.13) | HKEX:HK$20.94 (+0.32) | AIM:£2.03 (-0.05)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor